Labshake search
Citations for Bio X Cell :
1 - 50 of 152 citations for 7 Hydroxy 4 methylcoumarin 3 acetic acid succinimidyl ester since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2023Quote: ... anti-TIM3 Ab (4 μg/ml, clone RMT-3-23, BioXCell, Lebanon, NH), or 25-hydroxycholesterol (4 μM ...
-
bioRxiv - Immunology 2023Quote: ... injections every 3-4 days with 200 µg irrelevant antibody (clone 2A3, BioXCell), αPD-1 (clone RMP1-14 ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 4 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Cancer Biology 2022Quote: ... anti-IL-7 (BioXCell, 10 µg/ml), rmIL-7 or respective combinations ...
-
bioRxiv - Immunology 2022Quote: ... and anti-CD8 (clone 53.6-7, BioXcell) antibodies intraperitoneally twice per week ...
-
bioRxiv - Immunology 2022Quote: ... mice were rechallenged with 5×105 B16F10 GFP-LUC cells on day 75 post T cell transfer with or without intraperitoneal injection of 250 μg anti-Thy1.1 antibody (Days −7, 0, 7, 14, 21, 28, 35) (BioXCell) to deplete adoptively transferred pmel-1 T cells that are Thy1.1 expressing ...
-
bioRxiv - Immunology 2021Quote: ... 1% GlutaMAX™ and 1% N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid [Gibco® HEPES]) and used as follow: TH1 conditions with anti–IL-4 (10 μg/mL, BioXCell, #BE0045) and IL-12 (10 ng/mL ...
-
bioRxiv - Cancer Biology 2022Quote: ... transduced cells were split and cultured with either recombinant murine (rm)IL-7 or 10 µg/ml neutralizing anti-IL-7 antibody (BE0048, Bio X Cell). Same protocol applied for STAT5ca-RV transduction ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 5 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Immunology 2023Quote: NK cells were depleted from C57BL/6 mice starting at 3-4 weeks of age by intraperitoneal injection of 200 µg of anti-NK1.1 mAb (clone PK136, Bio X Cell) every 5 days for 3 weeks.
-
bioRxiv - Immunology 2021Quote: ... and anti-IL-4 (BioXCell); for Th2 ...
-
bioRxiv - Immunology 2022Quote: ... Tim-3 was neutralized using InVivoMAb anti-mouse Tim-3 antibodies (10µg/mL) (Bio X Cell, Lebanon, NH) for 1 h prior to rBma-LEC-1 or rBma-LEC-2 treatment.
-
bioRxiv - Immunology 2020Quote: ... or anti-LAG-3 (clone C9B7W, BioXcell) and/or anti-PD-L1 (10F.9G2 ...
-
bioRxiv - Immunology 2020Quote: ... LFA blocking antibody (M17/4; BioXCell) was administered i.p ...
-
bioRxiv - Cancer Biology 2020Quote: ... and anti-CTLA-4 (BioXCell, BE0164) or isotype control (MSD IgG1 control for muDX400 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and anti-CTLA-4 (BioXCell # BE0164) were diluted in PBS and dosed at 10 mg/kg every 3 days ...
-
bioRxiv - Immunology 2021Quote: ... or anti-TIM-3 (clone RMT3-23, BioXcell), followed by single injections of 100 μg antibody on two consecutive days ...
-
bioRxiv - Immunology 2024Quote: ... and IL-4-reactive monoclonal antibodies for in vivo studies (IL-4 MAb) were purchased from BioXCell (BE0045). All TLR agonists were purchased from Invivogen ...
-
bioRxiv - Immunology 2019Quote: ... anti-IL-4 (BioXcell, 11B11, 10ug/mL), IL-12 (Peprotech ...
-
bioRxiv - Cancer Biology 2021Quote: ... and anti-4-1BB (clone LOB12.3, BioXCell) treatment ...
-
bioRxiv - Immunology 2022Quote: ... and 3μg/mL anti–IL-4 (BioXcell) were used ...
-
bioRxiv - Immunology 2023Quote: Studies of anti-CTLA-4 (BE0032, BioXcell) therapy in mice bearing CT26 and B16 tumors ...
-
bioRxiv - Immunology 2023Quote: ... anti-LAG-3 mAb (clone C9B7w, Bio X Cell)9 ...
-
bioRxiv - Immunology 2022Quote: ... Inhibition of CTLA-4 signaling was performed by intraperitoneal injection of 500μg/dose of αCTLA-4 (clone: UC10-4F10-11, BioXcell) supplemented with 1mg/dose of IgG2b isotype (clone ...
-
bioRxiv - Immunology 2021Quote: ... InVivoMAb anti-mouse/human integrin β7 (clone FIB504, BE0062) and InVivoMAb rat IgG2a isotype control, anti-trinitrophenol (clone 2A3, BE0089) antibodies were purchased from BioXCell.
-
bioRxiv - Neuroscience 2024Quote: ... MMTV-PyMT +/- female mice at 7 weeks after the tumor onset were intravenously injected with the anti-PD-L1 antibody (BioXcell, #BE0101 ...
-
bioRxiv - Immunology 2020Quote: ... and anti-IL-4 (10 µg/ml, BioXCell). Th1 cells were then cultured ...
-
bioRxiv - Immunology 2022Quote: ... anti-CTLA-4 (clone: UC10-4F10-11, BioXcell) or isotype control antibodies (clone ...
-
bioRxiv - Immunology 2023Quote: ... and anti-IL-4 antibody (clone 11B11, BioXCell) at a concentration of 10 µg/ml ...
-
bioRxiv - Immunology 2023Quote: ... and anti-IL-4 Ab (clone 11B11, BioXCell) at a concentration of 10 µg/ml ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 200 µg of anti-CTLA-4 (BioXCell BE0164), or 400 µg of anti-IgG2b isotype control (BioXCell BE0090) ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 200 μg anti-CTLA-4 (clone 9H10, BioXcell), or their respective IgG controls ...
-
bioRxiv - Immunology 2022Quote: ... anti–mIL-4 (8 μg/mL, Bio X Cell), and anti–mIFN-γ (8 μg/mL ...
-
bioRxiv - Cancer Biology 2020Quote: ... anti-IL-6 or anti-CTLA-4 antibodies (BioXCell). For CXCR3 blockade studies ...
-
bioRxiv - Immunology 2021Quote: ... anti–mIL-4 (8 μg/mL, Bio X Cell), and anti–mIFN-γ (8 μg/mL ...
-
bioRxiv - Immunology 2020Quote: ... and anti-IL-4 (clone 11B11, Bio X Cell). Briefly ...
-
bioRxiv - Immunology 2022Quote: ... 15 and αCTLA-4 (9H10; BioXcell; 200 μg/dose) on days 0 ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti-4-1BB (clone LOB12.3, Bio X Cell #BP0169), anti-PD-1 (clone 29F.1A12 ...
-
bioRxiv - Immunology 2021Quote: ... and CTLA-4 blocking antibody (clone 9D9, BioXCell, cat. BE0164) were administered either in combination or as single agents at 100ug/antibody/mouse every third day starting on the day of doxycycline diet addition for four total doses.
-
bioRxiv - Microbiology 2020Quote: ... and 25 μg of anti-IL-4 (BioXcell, clone 11B11) were complexed prior to intraperitoneally injection into mice ...
-
bioRxiv - Cancer Biology 2019Quote: ... mice were randomized and treated with αCTLA-4 (BioXCell, BP0164) or isotype control (BioXcell ...
-
bioRxiv - Cancer Biology 2021Quote: ... anti-4-1BB agonist (5 mg/kg, clone: 3H3, BioXcell), or anti-PD-1 (10 mg/kg ...
-
bioRxiv - Immunology 2021Quote: ... TREG conditions: anti–IL-4 (10 μg/mL, BioXCell, #BE0045), anti-IFN-γ (10 μg/mL ...
-
bioRxiv - Immunology 2022Quote: ... and 10 μg/mL a-IL-4 (clone 11B11, BioXCell). For Th17 conditions ...
-
bioRxiv - Immunology 2023Quote: ... Tumor-bearing mice were treated with anti-CTLA-4 (BioXCell) (n=8 ...
-
bioRxiv - Cancer Biology 2024Quote: ... and anti-CTLA-4 (clone 9D9, Bio X Cell, #BE0164) were performed as part of this study ...
-
bioRxiv - Cell Biology 2021Quote: ... (2) aged-matched control mice (n=7) that received weekly IP injections of the isotype control IgG2A antibody (2A3, Bio X Cell, Lebanon, NH) at 12 mg/kg for 8 weeks ...
-
bioRxiv - Immunology 2021Quote: ... plus 2 µg/mL anti-IL-4 antibody (BioXcell, Clone: 11B11); Th17 ...
-
bioRxiv - Immunology 2019Quote: ... αIL-4 (5 μg mL−1, clone 11B11; Bio X Cell), rhTGF-β1 (2 ng mL−1 ...
-
bioRxiv - Immunology 2019Quote: ... complexed to 25 μg anti-IL-4 antibody (clone 11B11; BioXcell) in 100 μL sterile Phosphate buffered saline (PBS ...